These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37026883)

  • 21. Nonsteroidal anti-inflammatory drugs hypersensitivity in chronic spontaneous urticaria in the light of its pathogenesis.
    Asero R
    Eur Ann Allergy Clin Immunol; 2022 Jul; 54(4):189-191. PubMed ID: 34284571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consecutive injections of low-dose interleukin-2 improve symptoms and disease control in patients with chronic spontaneous urticaria.
    Wang J; He L; Yi W; Liang Q; Jiang L; Tan Y; Zhang G; Su Y; Xiao R; Lu Q; Long H
    Clin Immunol; 2023 Feb; 247():109247. PubMed ID: 36724835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis.
    Shaker M; Oppenheimer J; Wallace D; Lang DM; Rambasek T; Dykewicz M; Greenhawt M
    J Allergy Clin Immunol Pract; 2020; 8(7):2360-2369.e1. PubMed ID: 31751758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
    Skander D; Allenova A; Maurer M; Kolkhir P
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients.
    Balp MM; Weller K; Carboni V; Chirilov A; Papavassilis C; Severin T; Tian H; Zuberbier T; Maurer M
    Pediatr Allergy Immunol; 2018 Sep; 29(6):630-636. PubMed ID: 29679413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
    Melé-Ninot G; Serra-Baldrich E; Spertino J; Guilarte M; Ribó González P; Lleonart-Bellfill R; Figueras-Nart I; Bonfill-Ortí M; Depreux N; Sala-Cunill A; Bielsa-Marsol I; Baliu-Piqué C; Sanmartín-Novell V; Garcia-Navarro X; Expósito-Serrano V; Garnica-Velandia D; Diaz-Sarrió MC; Gómez-Armayones S; Gich Saladich I; Giménez-Arnau A
    Eur J Dermatol; 2022 Sep; 32(5):629-631. PubMed ID: 36468733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of patients with chronic spontaneous urticaria associated with autoimmune thyroiditis.
    Debbaut A; Gilliaux O
    Arch Pediatr; 2023 Apr; 30(3):131-135. PubMed ID: 36804356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study.
    Hide M; Fukunaga A; Suzuki T; Nakamura N; Kimura M; Sasajima T; Kiriyama J; Igarashi A
    Allergol Int; 2023 Apr; 72(2):286-296. PubMed ID: 36272899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic drugs in chronic spontaneous urticaria.
    Licari A; Manti S; Leonardi S; Minasi D; Caffarelli C; Cardinale F; Miraglia Del Giudice M; Calvani M; Ciprandi G; Marseglia GL
    Acta Biomed; 2021 Nov; 92(S7):e2021527. PubMed ID: 34842589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
    Atefi N; Fallahpour M; Sharifi S; Ghassemi M; Roohaninasab M; Goodarzi A
    Eur Ann Allergy Clin Immunol; 2022 May; 54(3):123-130. PubMed ID: 33939347
    [No Abstract]   [Full Text] [Related]  

  • 31. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
    Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical variables of severe chronic spontaneous urticaria from total IgE standpoint: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2022 Jan; 54(1):30-33. PubMed ID: 33555151
    [No Abstract]   [Full Text] [Related]  

  • 33. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria.
    Liu R; Peng C; Jing D; Xiao Y; Zhu W; Zhao S; Zhang J; Chen X; Li J
    Exp Dermatol; 2022 Feb; 31(2):242-247. PubMed ID: 34558729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New markers to predict the response to omalizumab in chronic spontaneous urticaria.
    Coşansu NC; Kara RÖ; Yaldiz M; Dikicier BS
    Dermatol Ther; 2022 Aug; 35(8):e15589. PubMed ID: 35582853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.
    He ZH; Qiu SC; Huang ZW; Zhang GQ; An QQ; Qu F; Wang N
    Dermatol Ther; 2022 Dec; 35(12):e15928. PubMed ID: 36222320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why.
    Metz M; Altrichter S; Buttgereit T; Fluhr JW; Fok JS; Hawro T; Jiao Q; Kolkhir P; Krause K; Magerl M; Pyatilova P; Siebenhaar F; Su H; Terhorst-Molawi D; Weller K; Xiang YK; Maurer M
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2274-2283. PubMed ID: 33857657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between Blastocystis spp. with Accompanying Food Hypersensitivity and Chronic Spontaneous Urticaria.
    Tuzer C; Yegit O; Ozturk NS; Demir S; Demirpek U; Boral OB; Buyukozturk S; Gelincik A; Colakoglu B
    Int Arch Allergy Immunol; 2022; 183(12):1259-1269. PubMed ID: 36108617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort.
    Rauscher C; Petrov AA; Fajt ML
    Curr Drug Saf; 2021; 16(1):97-100. PubMed ID: 33006537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
    Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.
    Sirufo MM; Bassino EM; De Pietro F; Ginaldi L; De Martinis M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211065870. PubMed ID: 35170369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.